Before you sell to, join or invest in Organogenesis Holdings Inc.
MentionFox check on Organogenesis Holdings Inc.: only 1 source on file so far (checked 8 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/organogenesis-holdings-inc-form-d-24000001
Check Organogenesis Holdings Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Organogenesis Holdings Inc. filed a Form D with the Securities and Exchange Commission on 2024-11-27.
Organogenesis Holdings Inc. filed a Form D notice of an exempt securities offering with the SEC on November 27, 2024. The filing reports $130M sold. Its industry group is Biotechnology. It names Alan Ades (Director), Robert Ades (Director), Michael Driscoll (Director) (SEC Form D, November 27, 2024).
Is this your company?
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Sell to companies like Organogenesis Holdings Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2024-11-27 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Organogenesis Holdings Inc.
Free to see. No signup.
Get an email when Organogenesis Holdings Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Organogenesis Holdings Inc. raises, hires or launches. No email unless you switch it on.
Watch Organogenesis Holdings Inc. →Get the full cited report on Organogenesis Holdings Inc.
What the filing shows about Organogenesis Holdings Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Organogenesis Holdings Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Organogenesis Holdings Inc.'s address as 85 Dan Road, Canton, MA 02021.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Organogenesis Holdings Inc. See pricing
Organogenesis Holdings Inc. is a registered filer with the SEC (CIK 1661181) and has filed since 2024-11-27. 1 filing is on record, the latest on 2024-11-27.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Organogenesis Holdings Inc.'s Form D of 2024-11-27 names Alan Ades, Robert Ades, Michael Driscoll and 15 more as its officers, directors or promoters.
Its new offerings report $130M sold across 1 offering, as its own filings state.
Trailing twelve months. 763 filings in Biotechnology, totalled by week.
Includes amounts paid or to be paid for share repurchases from related persons.
Alan Ades is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Robert Ades is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Michael Driscoll is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Prathyusha Duraibabu is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
David Erani is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Jon Giacomin is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Gary Gillheeney, Sr. is named as Executive Officer and Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Michele Korfin is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Arthur Leibowitz is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Glenn Nussdorf is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Gilberto Quintero is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Patrick Bilbo is named as Executive Officer on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
David Francisco is named as Executive Officer on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Lori Freedman is named as Executive Officer on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Brian Grow is named as Executive Officer on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Garrett Lustig is named as Director on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Antonio Montecalvo is named as Executive Officer on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
Robert Cavorsi is named as Executive Officer on the Form D that Organogenesis Holdings Inc. filed with the SEC on 27 November 2024, one of 18 people that filing names.
18 people named on the filing — 7 holding an executive role and 11 as directors only.
Named as of the 2024-11-27 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Of the 18 names on this filing, 12 are drawn here to keep the picture readable. The People tab lists them all.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Organogenesis Holdings Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Organogenesis Holdings Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Organogenesis Holdings Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Organogenesis Holdings Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Organogenesis Holdings Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Organogenesis Holdings Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/organogenesis-holdings-inc-form-d-24000001